Avalon BioVentures
Investor / VC · VC
· La Jolla, CA
Pure-play biotech VC spun out of Avalon Ventures in 2022. $135M Fund I. Managing Partners: Jay Lichter, Sandy Madigan, Tighe Reardon, Sergio Duron. Kevin Kinsella = Emeritus Partner. Incubation model with in-house labs. Notable exits: Nerio Therapeutics ($1.3B, Boehringer Ingelheim 2024), Calporta ($576M Merck).
Founded
2022
People
5
AUM
$135M
Region
Greater Los Angeles